Why the study?
Does percutaneous coronary intervention compared to coronary artery bypass grafting improve clinical outcomes in diabetic patients with coronary artery disease?
Does percutaneous coronary intervention compared to coronary artery bypass grafting improve clinical outcomes in diabetic patients with coronary artery disease?
This review summarizes the current evidence comparing PCI and CABG for revascularization in high-risk diabetic patients with CAD.
Answers are grounded in this paper and cite their sources.
Highlights ongoing equipoise between PCI and CABG in high-risk diabetic CAD; leaves open optimal strategy for future trials.
Patients with diabetes mellitus are at increased risk of developing coronary artery disease (CAD) and have an increased incidence of recurrent events following revascularization. Choosing the most appropriate strategy to revascularize these high-risk patients is crucial for improving the clinical outcomes. Several studies, randomized trials and meta-analyses have compared short- and long-term outcomes following coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in diabetic patients suffering from CAD. The aim of this article is to review the currently available evidence on the role of PCI and CABG in the management of diabetic patients with CAD.
No takes yet. Share an insight, caveat, or question.
Kassimis et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: